A clinical study of polyethylene glycol recombinant human granulocyte colony-stimulating factor prevention neutropenia syndrome in patients with esophageal carcinoma and lung cancer after concurrent chemoradiotherapy.
J Cancer Res Ther
; 13(5): 790-795, 2017.
Article
in En
| MEDLINE
| ID: mdl-29237905
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Polyethylene Glycols
/
Esophageal Neoplasms
/
Carcinoma
/
Antineoplastic Combined Chemotherapy Protocols
/
Granulocyte Colony-Stimulating Factor
/
Chemoradiotherapy
/
Chemotherapy-Induced Febrile Neutropenia
/
Lung Neoplasms
Type of study:
Etiology_studies
/
Incidence_studies
/
Prognostic_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Cancer Res Ther
Journal subject:
NEOPLASIAS
/
TERAPEUTICA
Year:
2017
Type:
Article
Affiliation country:
China